The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy

Mabel Yau; Joshua D. Safer

doi:10.1016/j.xcrm.2022.100835

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy

Research output: Contribution to journal › Comment/debate

Abstract

Fertility has become a priority in transgender health research. In this issue of Cell Reports Medicine, a study by de Nie et al.¹ of nine transgender women demonstrates sperm production after the cessation of gender-affirming hormone therapy (GAHT). Their results suggest the transient nature of gonadal suppression by GAHT.

Original language	English
Article number	100835
Journal	Cell Reports Medicine
Volume	4
Issue number	1
DOIs	https://doi.org/10.1016/j.xcrm.2022.100835
State	Published - 17 Jan 2023

Access to Document

10.1016/j.xcrm.2022.100835

Cite this

@article{8d98904f2f7a425faf76f9348639adfa,

title = "The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy",

abstract = "Fertility has become a priority in transgender health research. In this issue of Cell Reports Medicine, a study by de Nie et al.1 of nine transgender women demonstrates sperm production after the cessation of gender-affirming hormone therapy (GAHT). Their results suggest the transient nature of gonadal suppression by GAHT.",

author = "Mabel Yau and Safer, {Joshua D.}",

note = "Funding Information: The authors declare no competing interests. Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2023",

month = jan,

day = "17",

doi = "10.1016/j.xcrm.2022.100835",

language = "English",

volume = "4",

journal = "Cell Reports Medicine",

issn = "2666-3791",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy

AU - Yau, Mabel

AU - Safer, Joshua D.

PY - 2023/1/17

Y1 - 2023/1/17

N2 - Fertility has become a priority in transgender health research. In this issue of Cell Reports Medicine, a study by de Nie et al.1 of nine transgender women demonstrates sperm production after the cessation of gender-affirming hormone therapy (GAHT). Their results suggest the transient nature of gonadal suppression by GAHT.

AB - Fertility has become a priority in transgender health research. In this issue of Cell Reports Medicine, a study by de Nie et al.1 of nine transgender women demonstrates sperm production after the cessation of gender-affirming hormone therapy (GAHT). Their results suggest the transient nature of gonadal suppression by GAHT.

UR - http://www.scopus.com/inward/record.url?scp=85146282133&partnerID=8YFLogxK

U2 - 10.1016/j.xcrm.2022.100835

DO - 10.1016/j.xcrm.2022.100835

M3 - Comment/debate

C2 - 36652904

AN - SCOPUS:85146282133

SN - 2666-3791

VL - 4

JO - Cell Reports Medicine

JF - Cell Reports Medicine

IS - 1

M1 - 100835

ER -

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy

Abstract

Access to Document

Fingerprint

Cite this